For instance, the immunoinflammatory types of tumors respond efficiently to immunotherapeutic strategies like inhibition of ICs (with anti-PD-L1/PD-1 therapy), owing to the pre-existing anti-tumor immune response that becomes rejuvenated by these agents. The gene discussed is CD274; the disease is neoplasm.